NASDAQ:WGS 16 December 2025

GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears

GeneDx shares fell 8.7% to $108.90 Tuesday afternoon after the company released a 2026 revenue forecast of $540 million to $555 million and projected positive adjusted net income. The company reported 2025 revenue of about $427 million and ended the year with $172 million in cash. Investors are watching for updates at the J.P. Morgan Healthcare Conference on Jan. 14.

13 January 2026

Biotechnology·NASDAQ:WGS·Stock Market

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx Holdings shares fell nearly 7% to around $140 intraday Tuesday after closing near $150.6. Trading volume was below average, with no major news driving the drop. The move followed a recent JAMA recognition for the company’s GUARDIAN newborn genomic screening study and several analyst price target hikes earlier in the week. Broader U.S. markets were also under pressure.

16 December 2025

NASDAQ:WGS·Stock Market

Nebius Group Stock Rises 4.2% on Q1 Earnings and AI Infrastructure Growth
April 30, 2026, 5:17 AM EDT. Shares of Nebius Group (NASDAQ: NBIS) climbed 4.2% following its Q1 2026 earnings report and strong contract backlog momentum. The Amsterdam-based AI infrastructure firm reported revenue growth expectations soaring from $227.7 million in Q4 2025 to a forecast $375 million in Q1, despite analyst predictions of a $0.81 loss per share. Backed by Nvidia's $2 billion equity investment, Nebius holds a $46 billion revenue backlog anchored by major contracts from Meta Platforms and Microsoft. The company's aggressive $16-$20 billion 2026 capital expenditure plan is supported by a recent $4 billion convertible debt raise. Full-year revenue guidance projects a sixfold jump to $3-$3.4 billion. Analysts mostly rate the stock a Strong Buy, though skepticism remains over valuation multiples and execution risks due to recent insider selling and past revenue misses.

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

30 April 2026

Australian shares fell for an eighth straight session Thursday, with the S&P/ASX 200 closing down 0.24% at 8,665.8 as miners and consumer staples dropped. The decline followed data showing annual inflation rose to 4.6% in March, above the Reserve Bank’s target. Woolworths shares slid up to 9.8% after warning on earnings. Oil prices hit a four-year high, lifting energy stocks 1.4%.

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

30 April 2026

The FTSE 100 rose 0.10% to 10,222.85 in early London trading, recovering after a 1.2% drop on Wednesday. DCC shares fell 5% after rejecting a £4.95 billion takeover bid from KKR and Energy Capital Partners. Unilever began a €1.5 billion share buyback and posted 3.8% underlying sales growth. Investors awaited the Bank of England’s rate decision, with no change expected.

US Stock Market Before the Open Today: Oil Shock, Fed Split and Big Tech Earnings Put AI Rally on Trial

30 April 2026

U.S. stock futures fell early Thursday as Brent crude hit its highest level since March 2022, driven by concerns over U.S.-Iran tensions. The Federal Reserve left rates unchanged in its most divided vote since 1992, shifting focus to inflation risks. Alphabet and Amazon posted strong cloud earnings, while Meta’s increased spending highlighted pressure in the sector.

NASDAQ:WGS 16 December 2025 - 13 January 2026

GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

Stock Market Today

Latest article

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

US Stock Market Before the Open Today: Oil Shock, Fed Split and Big Tech Earnings Put AI Rally on Trial